CIK: 1860609 - Address: C/O Revolution Medicines, Inc., 700 Saginaw Dr, Redwood City, CA 94063
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/4/24 16:05
10/31/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADM.d12424.84053320D
11/4/24 16:05
10/31/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADS.d-27154.140-5-2020D
7/10/24 16:36
7/9/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADM.d3616.80021220D
7/10/24 16:36
7/9/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADS.d-9544.000-2-1020D
5/20/24 20:01
5/16/24
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilMADOCEOS-1316.470-20-9212D
4/12/24 16:23
4/10/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADM.d3616.80021616D
4/12/24 16:23
4/10/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilCADS.d-8037.000-2-1216D
6/15/23 21:00
6/13/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilMAOChief StS-13724.050-6-4149D
5/18/23 20:36
5/16/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilMAOChief StS-28118.050-16-9155D
5/18/22 19:01
5/16/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagPatel SushilMAOChief CoS-15614.590-11-8130D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact